Literature DB >> 18455219

Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1.

Hanns Möhler1, Uwe Rudolph, Detlev Boison, Philipp Singer, Joram Feldon, Benjamin K Yee.   

Abstract

Adaptive purposeful behaviour depends on appropriate modifications of synaptic connectivity that incorporate an organism's past experience. At least some forms of such synaptic plasticity are believed to be mediated by NMDA receptors (NMDARs). Complementary interaction with inhibitory neurotransmission mediated by GABA(A) receptors, and upstream control of the excitability of NMDARs by glycine availability can greatly influence the efficacy of NMDAR mediated neuroplasticity, and thereby exert significant effects on cognition. Memory, selective attention or sensorimotor gating functions can be modified in mice with a reduction of alpha(5)GABA(A) receptors in the hippocampus or a selective deletion of glycine transporter 1 (GlyT1) in the forebrain. Both genetic manipulations altered the formation or persistence of associative links leading to distinct phenotypes on trace conditioning, extinction learning, latent inhibition, working memory, and object recognition. Behavioural assays of latent inhibition, prepulse inhibition, working memory, and sensitivity to psychostimulants in particular suggest that alpha(3) and alpha(5) subunit-containing GABA(A) receptors as well as GlyT1 are potential sites for ameliorating psychotic-like behaviour. Taken together, these results qualify distinct GABA-A receptor subtypes and GlyT1 as molecular targets for the development of a new pharmacology in the treatment of cognitive decline and psychotic symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455219     DOI: 10.1016/j.pbb.2008.03.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

2.  Thalamic post-inhibitory bursting occurs in patients with organic dystonia more often than controls.

Authors:  K Kobayashi; C C Liu; A L Jensen; J L Vitek; Z Mari; F A Lenz
Journal:  Brain Res       Date:  2013-10-11       Impact factor: 3.252

Review 3.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

4.  AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.

Authors:  J L Silverman; C F Oliver; M N Karras; P T Gastrell; J N Crawley
Journal:  Neuropharmacology       Date:  2012-07-16       Impact factor: 5.250

5.  Intact working memory in the absence of forebrain neuronal glycine transporter 1.

Authors:  Sylvain Dubroqua; Lucas Serrano; Detlev Boison; Joram Feldon; Pascual A Gargiulo; Benjamin K Yee
Journal:  Behav Brain Res       Date:  2012-02-08       Impact factor: 3.332

6.  Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.

Authors:  Deepak Cyril D'Souza; Nagendra Singh; Jacqueline Elander; Michelle Carbuto; Brian Pittman; Joanna Udo de Haes; Magnus Sjogren; Pierre Peeters; Mohini Ranganathan; Jacques Schipper
Journal:  Neuropsychopharmacology       Date:  2011-11-23       Impact factor: 7.853

7.  Impaired GABA(A) receptor endocytosis and its correlation to spatial memory deficits.

Authors:  Rachel Jurd; Stephen J Moss
Journal:  Commun Integr Biol       Date:  2010-03

8.  GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Authors:  Jenifer L Vohs; R Andrew Chambers; Giri P Krishnan; Brian F O'Donnell; Sarah Berg; Sandra L Morzorati
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-23       Impact factor: 5.176

9.  Glycine transporter 1 is a target for the treatment of epilepsy.

Authors:  Hai-Ying Shen; Erwin A van Vliet; Kerry-Ann Bright; Marissa Hanthorn; Nikki K Lytle; Jan Gorter; Eleonora Aronica; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

10.  Dorsal hippocampal progesterone infusions enhance object recognition in young female mice.

Authors:  Patrick T Orr; Michael C Lewis; Karyn M Frick
Journal:  Pharmacol Biochem Behav       Date:  2009-05-27       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.